Medicare pre-claim reviews for home health services saved an estimated $1.2 billion in Illinois between 2014 and 2023, cutting spending by 13%—but the same program had no statistically significant impact in Florida, North Carolina, or Ohio, according to a new study. Researchers found the reductions in Illinois were concentrated in areas with a history of home health fraud, particularly Cook County, where Chicago is located. The findings suggest such programs may only be effective in targeted regions rather than serving as a nationwide solution.
The study, published in Health Affairs, analyzed Medicare claims data from 2014 through 2023, comparing four states that implemented pre-claim reviews—Illinois, Florida, North Carolina, and Ohio—against states that did not. While Illinois saw a sharp decline in spending per beneficiary ($8.89 less per person), the other three states showed no meaningful change. The authors attributed Illinois’s success to its history of home health fraud, which made the program more effective in identifying and reducing unnecessary or fraudulent services.
Pre-claim reviews require home health agencies to submit documentation proving a patient is homebound and under a physician’s approved care plan before Medicare approves payment. The study’s authors noted that the reductions in Illinois were driven by fewer community-initiated home health services, not changes in spending per user. Importantly, there was no increase in hospitalizations, suggesting the program did not discourage necessary care.
Why Did Illinois See Such Dramatic Savings While Other States Did Not?
The study’s lead researchers pointed to two key factors: Illinois’s history of home health fraud and the geographic concentration of suspicious activity. Cook County, which includes Chicago, has long been a hotspot for Medicare fraud investigations, with multiple high-profile cases over the past decade. The authors wrote that the program’s effectiveness in Illinois was likely due to its ability to target services more susceptible to fraud, rather than acting as a broad cost-control measure.
In contrast, Florida, North Carolina, and Ohio—where pre-claim reviews had no significant impact—may have had different patterns of home health service delivery. The study’s authors suggested that variations in state-level compliance with Medicare’s coverage requirements could explain the lack of savings in those states. Additionally, the COVID-19 pandemic may have disrupted the program’s effectiveness, as lockdowns and shifting care needs altered home health service demand.
According to the study, the $1.2 billion in savings in Illinois was achieved without increasing hospitalizations, a key concern when implementing prior authorization programs. The authors emphasized that while pre-claim reviews can reduce spending in high-fraud areas, they do not guarantee uniform savings across all regions. “Policy makers should be cognizant of this potential heterogeneity in designing future prior authorization programs,” they concluded.
How Pre-Claim Reviews Work—and What They’re Designed to Prevent
Medicare’s pre-claim review program for home health services is part of a broader effort to combat fraud and abuse in the healthcare system. Under the program, agencies must submit documentation—such as physician orders, patient assessments, and proof of homebound status—before Medicare processes a claim. This upfront review is designed to ensure that only medically necessary services are reimbursed.
The study’s authors analyzed data from the Medicare Master Beneficiary Summary File and the Medicare Provider Analysis and Review file, which track traditional Medicare claims nationwide. They focused on community-initiated home health care, where patients or their families arrange services independently, as this category has historically been more vulnerable to fraud.
One of the study’s most notable findings was that per-user spending did not change significantly under pre-claim review. Instead, the reductions came from fewer services being initiated in the first place. This suggests that the program may have discouraged unnecessary or fraudulent enrollments rather than cutting back on legitimate care.
What This Means for Medicare’s Future—and Who Stands to Benefit
The study’s results have implications for how Medicare and other payers approach prior authorization programs. While the Illinois experience shows that such measures can yield substantial savings in high-risk areas, the lack of impact in other states raises questions about their scalability. Experts suggest that targeted implementation, rather than a one-size-fits-all approach, may be the key to success.
For home health agencies, the findings underscore the importance of compliance with Medicare’s documentation requirements. Agencies in high-fraud regions may face stricter scrutiny, while those in lower-risk areas could see fewer changes to their operations. Meanwhile, beneficiaries in Illinois appear to have maintained access to necessary care, as evidenced by stable hospitalization rates.
The study also highlights a broader challenge in healthcare policy: balancing cost control with patient access. While pre-claim reviews can reduce fraudulent spending, they risk creating administrative burdens for providers and potential delays in care. The authors noted that the study’s limitations—such as not measuring beneficiary satisfaction or caregiver burden—mean the full impact of the program remains unclear.
What Happens Next? Key Questions for Policymakers
As Medicare continues to refine its fraud prevention strategies, several questions remain unanswered:
- Will CMS expand pre-claim reviews to other high-fraud regions? The Illinois success suggests targeted rollouts could be effective, but broader implementation may require additional data.
- How will the program adapt to post-pandemic care trends? The COVID-19 pandemic disrupted home health services, and its long-term effects on fraud patterns are still unfolding.
- What patient-centered outcomes are being measured? The study focused on hospitalizations, but other metrics—such as quality of care or beneficiary experiences—could provide a fuller picture.
- Could similar programs work for other Medicare services? The study’s authors cautioned that findings may not apply to services beyond home health.
For now, the Illinois case study offers a cautionary note for policymakers: Medicare’s pre-claim review program is not a universal solution. Its effectiveness depends on local fraud risks, compliance levels, and the broader healthcare landscape. As CMS evaluates future expansions, the Illinois experience will likely serve as a critical benchmark.
Where to Find Official Updates and Resources
Readers seeking more information on Medicare’s pre-claim review program can consult the following official sources:
- Centers for Medicare & Medicaid Services (CMS) – Official Medicare policies and updates.
- Medicare.gov – Beneficiary resources and claim processes.
- Health Affairs – Full study details and methodology.
The next major checkpoint for Medicare policy will be the 2025 Medicare Physician Fee Schedule final rule, expected in November 2024. This rule will outline updates to payment policies, including potential adjustments to pre-claim review programs based on emerging data.
Have insights or experiences with Medicare’s pre-claim review process? Share your thoughts in the comments below—or let us know if you’d like to see deeper coverage on how these programs affect specific regions.